STOCK TITAN
  1. Home
  2. Sec-filings
  3. MRMD
  4. [Form 4] MARIMED INC. Insider Trading Activity

MariMed (MRMD) Chief Commercial Officer receives 131,250 RSU equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MARIMED INC. Chief Commercial Officer Ryan Crandall reported receiving a grant of 131,250 Restricted Stock Units (RSUs), each representing one share of common stock. The RSUs were awarded at a price of $0.00 per unit as equity compensation.

The RSUs convert to common stock on a one-for-one basis and will vest in four equal installments on July 15, 2026, October 15, 2026, January 15, 2027, and April 15, 2027. Following this grant, Crandall directly holds 879,634 shares of common stock and 131,250 RSUs.

Positive

  • None.

Negative

  • None.

Insights

Routine RSU grant to officer with multi-year vesting, no market buying or selling.

Chief Commercial Officer Ryan Crandall received 131,250 RSUs at a grant price of $0.00, a standard form of stock-based compensation. The units convert into common stock on a one-for-one basis as they vest, aligning part of his pay with future company performance.

The vesting is spread over four equal installments on July 15, 2026, October 15, 2026, January 15, 2027, and April 15, 2027, promoting retention over roughly one year. No open-market purchases or sales are reported, and the filing shows his direct common stock holdings at 879,634 shares after the award, indicating this is a compensation event rather than a trading signal.

Insider Crandall Ryan
Role Chief Commercial Officer
Type Security Shares Price Value
Grant/Award Restricted Stock Units (RSU) 131,250 $0.00 --
holding Common stock -- -- --
Holdings After Transaction: Restricted Stock Units (RSU) — 131,250 shares (Direct); Common stock — 879,634 shares (Direct)
Footnotes (1)
  1. RSUs convert to shares of common stock on a one-for-one basis. The RSUs will vest in four equal installments on each of July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.
RSUs Granted 131,250 units Grant of Restricted Stock Units to CCO on April 15, 2026
RSU Grant Price $0.00 per unit Equity compensation award with no cash consideration
Underlying Shares 131,250 shares RSUs convert to common stock on a one-for-one basis
Post-grant Common Shares 879,634 shares Direct common stock holdings following reported transactions
First Vesting Date July 15, 2026 First of four equal RSU vesting installments
Final Vesting Date April 15, 2027 Last of four equal RSU vesting installments
Restricted Stock Units (RSU) financial
"Restricted Stock Units (RSU) convert to shares of common stock"
one-for-one basis financial
"RSUs convert to shares of common stock on a one-for-one basis"
vesting financial
"The RSUs will vest in four equal installments on each of the stated dates"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant, award, or other acquisition financial
"transaction code description notes Grant, award, or other acquisition"
Form 4 regulatory
"INSIDER FILING DATA (Form 4) for MARIMED INC."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Crandall Ryan
(Last)(First)(Middle)
C/O MARIMED INC.
10 OCEANA WAY
(Street)
NORWOOD MASSACHUSETTS 02062
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Commercial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock879,634D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (RSU)(1)04/15/2026A131,250 (2) (2)Common Stock, par value $.001 per share131,250$0131,250D
Explanation of Responses:
1. RSUs convert to shares of common stock on a one-for-one basis.
2. The RSUs will vest in four equal installments on each of July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.
Remarks:
The RSUs were granted in lieu of cash payment of a portion of the Reporting Person's annual bonus for the fiscal year ended December 31, 2025.
/s/ Ryan Crandall04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did MARIMED INC. (MRMD) disclose about Ryan Crandall in this Form 4?

MARIMED INC. reported that Chief Commercial Officer Ryan Crandall received a grant of 131,250 Restricted Stock Units (RSUs). These equity awards are compensation, not open-market trades, and convert into common stock on a one-for-one basis as they vest over time.

How many RSUs were granted to MARIMED INC. (MRMD) executive Ryan Crandall?

Ryan Crandall was granted 131,250 Restricted Stock Units. Each RSU represents the right to receive one share of MARIMED INC. common stock. The award was made at a grant price of zero, reflecting typical stock-based compensation rather than a market purchase transaction.

What is the vesting schedule for Ryan Crandall’s RSUs at MARIMED INC. (MRMD)?

The 131,250 RSUs vest in four equal installments. Vesting dates are July 15, 2026, October 15, 2026, January 15, 2027, and April 15, 2027. This staggered schedule encourages ongoing service and links compensation to MARIMED INC.’s future performance over that period.

Does the MARIMED INC. (MRMD) Form 4 show any stock buying or selling by Ryan Crandall?

The Form 4 shows an RSU grant to Ryan Crandall but no open-market purchases or sales. The main reportable event is a grant/award acquisition of 131,250 RSUs at a price of zero, which is standard non-cash equity compensation rather than a trading decision.

How many MARIMED INC. (MRMD) shares does Ryan Crandall hold after this RSU grant?

After the RSU grant, the filing lists Ryan Crandall holding 879,634 shares of MARIMED INC. common stock directly. In addition, he has 131,250 RSUs outstanding, which may settle into common shares as they vest according to the disclosed schedule.

What does the one-for-one RSU conversion mean for MARIMED INC. (MRMD) shareholders?

A one-for-one conversion means each RSU becomes one share of common stock upon vesting. For Ryan Crandall’s 131,250 RSUs, full vesting would result in the same number of additional common shares issued to him over time, reflecting standard executive equity compensation mechanics.